Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Common Gastrointestinal Issues The most frequent reports from patients starting this combination include: Nausea: This is the most common side effect of tirzepatide as the body adjusts to slower digestion
Indications and Efficacy: Obesity Treatment: In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%
It stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is released only when blood sugar levels are elevated
Brand-name GLP-1 medications are often prioritized for insured patients, leaving self-pay individuals with fewer options
